Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for …
$1.00+7.39%
报价 2026-11-06
市值
$120.1M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -56.5%
$0.93$2.29
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CRDLCardiol Therapeutics Inc. | $120.1M | +7.4% | – | 0% | – | – | – | |
| LFCRLifecore Biomedical, Inc. | $241.1M | -0.6% | +62.7% | 29.7% | – | – | – | |
| SIGASIGA Technologies, Inc. | $222.7M | +4.4% | -32.0% | – | – | – | – | |
| DERMJourney Medical Corporation | $126.2M | +4.0% | +31.1% | 68.4% | – | – | – | |
| OGIOrganigram Global Inc. | $123.6M | -5.7% | – | 39.2% | 2.6x | – | – | |
| BGMBGM Group Ltd. | $104.7M | -7.3% | – | 12.8% | – | – | 81.1x | |
| ORGOOrganogenesis Holdings Inc. | $104.6M | -3.2% | -44.9% | 67.6% | – | – | 5.2x | |
| CPIXCumberland Pharmaceuticals Inc. | $78.2M | +4.2% | -14.9% | 83.4% | – | – | – | |
| ZYBTZhengye Biotechnology Holding Limited | $71.1M | +8.7% | – | 8.3% | – | – | 14.0x | |
| 同行中位数 | – | – | -14.9% | 39.2% | 2.6x | – | 14.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 CAD（非美元）暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。